Results 151 to 160 of about 29,486 (214)

A Reanalysis of the FDA's Benefit-Risk Assessment of Moderna's mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection. [PDF]

Vaccines (Basel)
Bourdon PS, Duriseti R, Gromoll HC, Dalton DK, Bardosh K, Krug AE.   +5 more
europepmc   +1 more source

Longitudinal evaluation of anti-SARS-CoV-2 neutralizing antibody levels in 3-dose homologous (mRNA-1273- mRNA-1273- BNT162b2) vaccinated kidney transplant population: 18-month follow-up. [PDF]

IJID Reg
Karunathilake KRP, Kumara RA, Karunathilaka A, Wazil AWM, Nanayakkara N, Bandara CK, Abeysekera RA, Noordeen F, Gawarammana IB, Ratnatunga CN.   +9 more
europepmc   +1 more source

mRNA-1273/ravulizumab [PDF]

Reactions Weekly, 2021
openaire   +1 more source

Lymphocytic thrombophilic arteritis following mRNA-1273 severe acute respiratory syndrome coronavirus 2 vaccination: A case report and review of the literature

, 2023
Yichen Liao, Hsin‐Yu Huang, Cheng-Ju Wu, JuliaYu-Yun Lee, Chao‐Kai Hsu   +4 more
openalex   +1 more source

mRNA-1273 and Ad26.COV2.S Vaccines Protect Against the B.1.621 Variant of SARS-CoV-2

, 2022
Tamarand L. Darling, Baoling Ying, Bradley Whitener, Laura A. VanBlargan, Traci L. Bricker, Chieh-Yu Liang, Astha Joshi, Gayan Bamunuarachchi, Kuljeet Seehra, Aaron J. Schmitz, Peter Halfmann, Yoshihiro Kawaoka, Sayda M. Elbashir, Darin K. Edwards, Larissa B. Thackray, Michael Diamond, Adrianus C. M. Boon   +16 more
openalex   +1 more source

Dexamethasone/immune-globulin/mrna-1273

, 2022

openalex   +2 more sources

Safety and Immunogenicity of an mRNA-1273 Booster in Children. [PDF]

Clin Infect Dis
Berthaud V, Creech CB, Rostad CA, Carr Q, de Leon L, Dietrich M, Gupta A, Javita D, Nachman S, Pinninti S, Rathore M, Rodriguez CA, Luzuriaga K, Towner W, Yeakey A, Brown M, Zhao X, Deng W, Xu W, Zhou H, Girard B, Kelly R, Slobod K, Anderson EJ, Das R, Miller J, Schnyder Ghamloush S.   +26 more
europepmc   +1 more source

Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines. [PDF]

Cell Rep
Bangaru S, Jackson AM, Copps J, Fernández-Quintero ML, Torres JL, Richey ST, Nogal B, Sewall LM, Torrents de la Peña A, Rehman A, Guebre-Xabier M, Girard B, Das R, Corbett-Helaire KS, Seder RA, Graham BS, Edwards DK, Patel N, Smith G, Ward AB.   +19 more
europepmc   +1 more source

The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination. [PDF]

Sci Rep
Tarriño M, Gutiérrez-Bautista JF, Durán MJO, Garcia-Diaz A, Cabrera-Serrano AJ, Sainz J, Cobo F, Rodriguez T, Reguera JA, Bernal M, López-Nevot MÁ, Sampedro A.   +11 more
europepmc   +1 more source

Longitudinal Comparison of Three T-Cell Assays and Three Antibody Assays Against SARS-CoV-2 Following Homologous mRNA-1273/mRNA-1273/mRNA-1273 and Heterologous ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naïve Healthcare Workers. [PDF]

Vaccines (Basel)
Lee H, Ko GY, Lee J, Bae H, Ryu JH, Jung J, Kang H, Lee R, Lee DG, Oh EJ.   +9 more
europepmc   +1 more source